M

MED PE Valuation

This table applies MED's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

M

MED Earnings Per Share

This chart tracks MED's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

M

MED Quarterly Revenue

This chart tracks MED's quarterly revenue over time and shows how sales are changing from year to year.

M

MED Free Cash Flow

This chart tracks MED's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

M

MED Net Leverage

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

M

MED Weekly Price

This chart uses MED's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

M

MED Weekly Moving Averages

This chart compares MED's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

M

MED Yearly ROI

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.